Daiwa Securities Group Inc. Kaleido Biosciences, Inc. Transaction History

Daiwa Securities Group Inc.

  • $18.8 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022
SELL
$2.39 - $6.02 $162 - $409
-68 Closed
0 $0
Q4 2020

Feb 04, 2021
BUY
$5.77 - $11.33 $392 - $770
68 New
68 $1,000

About Kaleido Biosciences, Inc.

KLDO Quotes by TradingView
  • Ticker KLDO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,622,600
  • Description
  • Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...
More about KLDO
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email